Determinants of virological failure in HIV-infected children and adolescents on first-line anti retrovirals in three treatment centres in the Bamenda municipality, Cameroon
Journal of Tropical Pediatrics · 2026
DOI: 10.1093/tropej/fmag038 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Tropical Pediatrics, 2026. Verfasst von Andreas Chiabi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, University of Bamenda, Bamenda, Bambili, Cameroon. Hauptthemen laut MEDLINE: Viral Load, HIV Infections, Anti-HIV Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Virological failure is defined as a plasma viral load above 1000 copies/ml in a human immunodeficiency virus (HIV) patient after two consecutive viral load measurements 3 months apart, with adherence support after the first test and being on treatment for at least 6 months. It can lead to disease progression and increased risk of opportunistic infections. We conducted a retrospective cohort study using data from medical records of children and adolescents aged 6 weeks to 19 years receiving first-line antiretrovirals (ARVs) at three treatment centres in Bamenda: the Regional Hospital, Nkwen District Hospital, and St Mary Soledad Catholic Hospital. Data were collected over a 5-month period (January to May 2025) and included patients with at least 6 months on ART and two documented viral load measurements taken three months apart. Of 419 patients recruited, 169 had virological failure, giving a prevalence of 40.3%, with most being male (53.8%). The factors associated with virological failure included being male (aOR = 0.54; P < .008), having a caregiver who is single (aOR = 3.36; P < 0.001), having WHO clinical stage 3 and 4 at ARV initiation (aOR = 3.38; P = .038), fair or poor adherence to ARVs (aOR = 15.73; P < 0.001) and greater than 10 missed appointments (aOR = 33.76; P < .001). A total of 14 children and adolescents with virological failure died, resulting in a mortality rate of 8.3%. This study shows that the prevalence of virological failure was high in the three HIV treatment centres in this part of Cameroon.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Health Sciences, University of Bamenda, Bamenda, Bambili, Cameroon.
- Regional Hospital, Bamenda, Cameroon.
- Nkwen Baptist Hospital, Bamenda, Bamenda, Cameroon.
- Saint Mary Soledad Hospital, Bamenda, N11, Cameroon.
ORCID-Profile: Andreas Chiabi
Zitieren
APA
Chiabi, A., Nana, G., Fomenky, C., Angwafor, S., Tanlaka, L., Suiru, C., Geh, M. M., & Ashuntantang, G. E. (2026). Determinants of virological failure in HIV-infected children and adolescents on first-line anti retrovirals in three treatment centres in the Bamenda municipality, Cameroon. Journal of Tropical Pediatrics. https://doi.org/10.1093/tropej/fmag038
Vancouver
Chiabi A, Nana G, Fomenky C, Angwafor S, Tanlaka L, Suiru C, et al. Determinants of virological failure in HIV-infected children and adolescents on first-line anti retrovirals in three treatment centres in the Bamenda municipality, Cameroon. Journal of Tropical Pediatrics. 2026. doi:10.1093/tropej/fmag038
BibTeX
@article{Chiabi2026,
author = {Chiabi, Andreas and Nana, George and Fomenky, Cecilia and Angwafor, Samuel and Tanlaka, Lucas and Suiru, Claudia and Geh, Martin Meh and Ashuntantang, Gloria Enow},
title = {Determinants of virological failure in HIV-infected children and adolescents on first-line anti retrovirals in three treatment centres in the Bamenda municipality, Cameroon},
journal = {Journal of Tropical Pediatrics},
year = {2026},
doi = {10.1093/tropej/fmag038}
}
EUVIMED